A fresh delivery of hope arrives from the medical community, as the Chicago Tribune reports a major advance toward understanding how amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s Disease, erodes the ability of victims’ brains to control motor functions and respiration. It could have implications for treating other neurological disorders, including Alzheimer’s and Parkinson’s, as well.
The breakthrough in a paper from Drs. Teepu Siddique, Han-Xiang Deng, Wenjie Chen, and twenty other contributing scientists hinges on isolating a protein called “ubiquilin2”:
Amelie Gubitz, a research program director at the National Institute of Neurological Disorders and Stroke, said the Northwestern research is a big step forward in efforts worldwide to conquer ALS.
“You need to understand at the cellular level what is going wrong,” said Gubitz. “Then you can begin to design drugs.
“ALS is a complicated problem, and Dr. Siddique’s research adds a big piece to the puzzle that gives us important new insights.”